About Us

SkinBioTherapeutics is a life sciences company focused on advancing skin health across wellbeing, repair and beauty.

 

Our core focus is translating evidence-based science into products and intellectual property that could make a real difference to people’s skin. Our portfolio spans topical ingredients, oral supplements, intellectual property for outlicensing, and in-house services and manufacturing.

 

SkinBioTherapeutics plc is listed on the AIM market of the London Stock Exchange under the ticker SBTX. 

Meet the team.

Rachel Parsonage

Rachel Parsonage

Interim Chief Executive Officer

Read bio
Alyson Levett

Alyson Levett

Non-Executive Director

Read bio

Our Team

Melissa Greenwell

Group Financial Controller

Read bio

Vicky Christie

Group Marketing Manager

Read bio

Tom Waughman

Managing Director at Dermatonics

Read bio

Tim Wakeley

Managing Director at Bio-Tech Solutions

Read bio

Vanessa Ryder

Customer Service and Operations Manager

Read bio

Shahin Rahman

Scientific and Commercial Specialist

Read bio

Matthew Brown

Marketing Executive

Read bio